Results 171 to 180 of about 62,516 (342)
Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis
International Journal of Dermatology, EarlyView.ABSTRACT Background
Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang +26 morewiley +1 more sourceCharacteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry
Allergy, EarlyView.Stéphanie Wanin, Rola Abou Taam, Lisa Giovannini Chami, Christophe Marguet, Jocelyne Just, Christele Da Silva, Jérôme Msihid, Olivier Ledanois, Rebecca Gall, Harry J. Sacks, Juby A. Jacob‐Nara, Capucine Daridon, Antoine Deschildre +12 morewiley +1 more sourceOverlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study
Journal of Internal Medicine, EarlyView.Abstract Background
Granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA) are distinct forms of antineutrophil cytoplasm antibody (ANCA)‐associated vasculitis (AAV). Increasing evidence suggests overlapping features, particularly in proteinase 3 (PR3)‐ANCA‐positive EGPA and GPA with eosinophilia.Federica Pallotti, Camille Mettler, Matthias Papo, Michele Iudici, Roberto Padoan, Boris Sorin, Francesca Regola, Franco Franceschini, Sergey Moiseev, Pavel Novikov, Mario Andrea Piga, Gianluca Moroncini, Silke R. Brix, Abdul Hadi Kafagi, Samuel Deshayes, Achille Aouba, Julien Campagne, Paolo Delvino, Jan Willem Cohen Tervaert, Luisa Brussino, Martin Michaud, Nils Venhoff, Federico Alberici, Claudia Iannone, Sophie Rosenstingl, Marin Moutel, Jean‐Marc Galempoix, Vincent Cottin, Clara Jaccard, Diane Riehl, Paul Legendre, Anne Claire Billet, Paola Parronchi, Luca Quartuccio, Vitor Teixeira, Allyson Egan, David Jayne, Enrico Tombetti, Marco Caminati, Christian Pagnoux, Alexis Regent, Marc Ruivard, Loïc Guillevin, Xavier Puéchal, Benjamin Terrier, the French Vasculitis Study Group (FVSG) +45 morewiley +1 more sourceKaryometric analysis of nasal polyps.
Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat, 2006 Amaç: Bu çalışmada nazal polip epitel hücrelerinin çekirdek yapıları incelendi. Hastalar ve Yöntemler: Nazal polipozis nedeniyle ameliyat edilen 35 hastanın kesitleri ve 18 normal mukoza kesiti çalışıldı. Kesitler hematoksilen-eozin ile boyandı. Doku bölümleri CCD kamera ve Mac OS 9 Karyotype Program of Human Cytogenetics Nomenclature System yardımı ...Yildirim A., Ozdemir O., Gül E., Yildirim B., Elagöz S., Kunt T. +5 moreopenaire +6 more sourcesIdentification of a circRNA/miRNA/mRNA ceRNA Network as a Cell Cycle-Related Regulator for Chronic Sinusitis with Nasal Polyps
, 2022 Qi Sun, Zhen Liu, Xiangya Xu, Yujuan Yang, Xiao Han, Cai Wang, Fei Song, Yakui Mou, Yumei Li, Xicheng Song +9 moreopenalex +2 more sourcesOmalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review
Pediatric Dermatology, EarlyView.ABSTRACT
We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of ...Janis Chang, Aliyah King, Adam Byrne, Carmen Liy‐Wong +3 morewiley +1 more source